摘要
英国、法国、韩国的医保药品目录调整经验显示,成熟的药品价值评估体系、分类管理机制和风险分担体系发挥了重要作用。我国可以适当借鉴国际经验,创新医保药品目录的动态调整机制,完善药品分类管理体系,依托独立的卫生技术评估机构开展全流程药物评估,以及建立多方参与的风险分担体系,满足人民群众多元化医疗保障需求。
From the experience of adjusting the medical insurance drug catalog in the UK,France,and South Korea,it can be seen that mature drug value evaluation systems,classification management mechanisms,and risk sharing systems have played an important role.By appropriately drawing on international experience,we should innovate the dynamic adjustment mechanism of the medical insurance drug catalog,improve the drug classification management system,rely on independent health technology assessment institutions to conduct whole process drug evaluation,and establish a multi-party risk sharing system,in order to meet the diverse medical security demands of the people.
作者
郑王彪
郑超
孙强
ZHENG Wangbiao;ZHENG Chao;SUN Qiang(Centre for Health Management and Policy Research,School of Public Health,Cheeloo College of Medicine,Shandong University,Jinan Shandong 250012,China;不详)
基金
山东省重点研发计划(软科学项目)“医保区域不平衡对城乡医保统筹和经济社会协调发展的影响研究”(2022RKY07003)
中国博士后科学基金面上项目“新发展阶段医保政策解决因病致贫的长效机制研究”(2022M711941)
山东省社会科学规划研究项目“中共社会医疗保障百年经验对健康强省建设的启示”(21CXSXJ11)。
关键词
医保药品目录
动态调整机制
卫生技术评估
药品分类管理
medical insurance drug catalog
dynamic adjustment mechanism
health technology assessment
drug classification manag-ement
